SEK395.00
2.07% day before yesterday
Stockholm, Dec 27, 05:30 pm CET
ISIN
SE0009858152
Symbol
BONEX
Sector

Bonesupport Holding AB Stock price

SEK395.00
+23.20 6.24% 1M
+128.40 48.16% 6M
+206.80 109.88% YTD
+210.00 113.51% 1Y
+355.05 888.74% 3Y
+362.50 1,115.38% 5Y
+363.00 1,134.38% 10Y
Stockholm, Closing price Fri, Dec 27 2024
+8.00 2.07%
ISIN
SE0009858152
Symbol
BONEX
Sector

Key metrics

Market capitalization SEK26.01b
Enterprise Value SEK25.88b
P/E (TTM) P/E ratio 285.98
EV/FCF (TTM) EV/FCF 5,921.33
EV/Sales (TTM) EV/Sales 31.77
P/S ratio (TTM) P/S ratio 31.94
P/B ratio (TTM) P/B ratio 39.28
Revenue growth (TTM) Revenue growth 56.16%
Revenue (TTM) Revenue SEK814.46m
EBIT (operating result TTM) EBIT SEK106.17m
Free Cash Flow (TTM) Free Cash Flow SEK4.37m
Cash position SEK153.16m
EPS (TTM) EPS SEK1.38
P/E forward 202.22
P/S forward 28.72
EV/Sales forward 28.57
Show more

Is Bonesupport Holding AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Bonesupport Holding AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Bonesupport Holding AB forecast:

3x Buy
100%

Analyst Opinions

3 Analysts have issued a Bonesupport Holding AB forecast:

Buy
100%

Financial data from Bonesupport Holding AB

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
814 814
56% 56%
100%
- Direct Costs 62 62
37% 37%
8%
753 753
58% 58%
92%
- Selling and Administrative Expenses 575 575
37% 37%
71%
- Research and Development Expense 72 72
32% 32%
9%
116 116
977% 977%
14%
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 106 106
5,430% 5,430%
13%
Net Profit 91 91
58% 58%
11%

In millions SEK.

Don't miss a Thing! We will send you all news about Bonesupport Holding AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

BONESUPPORT HOLDING AB engages in the development and commercialization of injectable bioceramic bone graft substitutes to treat bone voids. It markets its products through its propriety CERAMENT technology platform. The firm's products focuses on the treatment of trauma, revision arthro-plasty, chronic osteomyelitis, and foot infections and ankle surgery. It operates through the North America, and Europe and Rest of the World geographical segments. The company was founded by Lars Åke Alvar Lidgren and Fredrik Lindberg in 1999 and is headquartered in Lund, Sweden.

Head office Sweden
CEO Emil Billbäck
Employees 118
Founded 2010
Website www.bonesupport.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today